Title of article :
Cytokines modulate cilomilast response in lung fibroblasts
Author/Authors :
Kohyama، نويسنده , , Tadashi and Liu، نويسنده , , Xiangde and Wen، نويسنده , , Fu-Qiang and Kobayashi، نويسنده , , Tetsu and Fang، نويسنده , , Qiuhong and Abe، نويسنده , , Shinji and Cieslinski، نويسنده , , Lenora and Barnette، نويسنده , , Mary S and Rennard، نويسنده , , Stephen I، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2004
Abstract :
Fibroblasts, as a major source of extracellular interstitial connective tissue matrix, play an important role in wound healing and the development of fibrosis. The phosphodiesterase (PDE) 4 inhibitor cilomilast inhibits fibroblast chemotaxis and fibroblast-mediated gel contraction. Using the Boyden blindwell chamber chemotaxis assay and the type I collagen gel contraction model, this study investigated whether specific cytokines modulate cilomilastʹs inhibitory effect through regulation of endogenous PGE2 production. Human recombinant IL-1β stimulated PGE2 production and shifted the cilomilast concentration–dependence curve to the left in both assay systems, indicating increased sensitivity to cilomilast. In contrast, human recombinant IL-4 inhibited PGE2 production and shifted the cilomilast concentration–dependence curve to the right in both systems. In summary, the inhibitory effect of cilomilast on fibroblast migration and collagen gel contraction is modulated by IL-1β and IL-4 through regulation of PGE2 production.
Keywords :
Lung , Wound healing , asthma , Cilomilast , Prostaglandin E2 (PGE2) , Chronic obstructive lung disease (COPD) , Human fetal lung fibroblasts , PDE4 inhibitors
Journal title :
Clinical Immunology
Journal title :
Clinical Immunology